6505-- Denosumab Injections

The solicitation requires offerors to submit a fully approved small‑business subcontracting plan (commercial or individual) in accordance with FAR 52.219‑9 and VAAR 852.219‑70 for any contract valued over $900,000. The plan must detail dollar and percentage goals for each subcontracting category (small business, veteran‑owned, HUBZone, women‑owned, etc.) for the base period and any five‑year option, include separate goals for each option period, and justify any goal that is lower than the VA‑suggested target or lower than the prior year’s achievement. Offerors must describe the methodology used to develop these goals, specify how potential sources were identified (listing exact websites, associations, events, etc.), and indicate whether indirect costs are included in the stated goals. In addition, the awardee must provide evidence of the API and final manufacturing processes that constitute a substantial transformation, and must price any alternate presentation (vial or syringe) of the same strength at the same contract price as the originally proposed form. The contract also mandates a good‑faith effort to ensure equitable opportunities for all small‑business categories, with specific internal and external outreach actions. All required provisions (e.g., FAR 52.204‑7, 52.214‑34/35) are available electronically, and the subcontracting plan must align with the contractor’s fiscal year or cover the entire performance period, with a new plan required 30 days before expiration if the fiscal year ends before contract completion.

Notice ID

4f6d63ed500d4aef82edab8ae6cee9be

Solicitation Number

36E79726R0018

NAICS Code

325412

Classification Code

6505